BIOMAT Database Logo BIOMAT Database Logo

Treatment of erythema nodosum leprosum with thalidomide. 1973

L Levy, and P Fasal, and N E Levan, and R I Freedman

UI MeSH Term Description Entries
D007918 Leprosy A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid. Hansen's Disease,Hansen Disease
D008297 Male Males
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D004893 Erythema Nodosum An erythematous eruption commonly associated with drug reactions or infection and characterized by inflammatory nodules that are usually tender, multiple, and bilateral. These nodules are located predominantly on the shins with less common occurrence on the thighs and forearms. They undergo characteristic color changes ending in temporary bruise-like areas. This condition usually subsides in 3-6 weeks without scarring or atrophy.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000305 Adrenal Cortex Hormones HORMONES produced by the ADRENAL CORTEX, including both steroid and peptide hormones. The major hormones produced are HYDROCORTISONE and ALDOSTERONE. Adrenal Cortex Hormone,Corticoid,Corticoids,Corticosteroid,Corticosteroids,Cortex Hormone, Adrenal,Hormone, Adrenal Cortex,Hormones, Adrenal Cortex
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013792 Thalidomide A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action. Sedoval,Thalomid

Related Publications

L Levy, and P Fasal, and N E Levan, and R I Freedman
Treatment of erythema nodosum leprosum with thalidomide.
September 1973, Lancet (London, England),
L Levy, and P Fasal, and N E Levan, and R I Freedman
[Treatment of erythema nodosum leprosum using thalidomide].
January 1983, Acta leprologica,
L Levy, and P Fasal, and N E Levan, and R I Freedman
Thalidomide in erythema nodosum leprosum.
May 1990, DICP : the annals of pharmacotherapy,
L Levy, and P Fasal, and N E Levan, and R I Freedman
[Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide].
October 2001, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
L Levy, and P Fasal, and N E Levan, and R I Freedman
Thalidomide in erythema nodosum leprosum (ENL)
June 1988, Leprosy review,
L Levy, and P Fasal, and N E Levan, and R I Freedman
Letter: Thalidomide in erythema nodosum leprosum.
November 1973, Lancet (London, England),
L Levy, and P Fasal, and N E Levan, and R I Freedman
Letter: Thalidomide in erythema nodosum leprosum.
October 1973, Lancet (London, England),
L Levy, and P Fasal, and N E Levan, and R I Freedman
Thalidomide in the treatment of erythema nodosum leprosum. With a note on selected laboratory abnormalities in erythema nodosum leprosum.
January 1970, Clinical pharmacology and therapeutics,
L Levy, and P Fasal, and N E Levan, and R I Freedman
Thalidomide levels in patients with erythema nodosum leprosum.
October 2009, Therapeutic drug monitoring,
L Levy, and P Fasal, and N E Levan, and R I Freedman
[Thalidomide used by patients with erythema nodosum leprosum].
January 2010, Revista da Sociedade Brasileira de Medicina Tropical,
Copied contents to your clipboard!